Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation
- PMID: 7503807
- DOI: 10.1016/0006-2952(95)02039-x
Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation
Abstract
We have shown previously that the lipophilic calcium channel blockers exhibit membrane antioxidant activity. In the present study, when attached bovine aortic endothelial cells were exposed for 20 min to a low concentration of oxy-radicals generated from dihydroxyfumarate + Fe-ADP, no loss of glutathione or viability was detected; however, cell number, determined 48 hr later by the tetrazolium salt MTT assay, decreased to 45% of controls. Treatment of the cells for 1 hr with the calcium blockers (2-20 microM) prior to free radical exposure protected against the impaired cell growth in a concentration-dependent manner. The order of potency was nicardipine > or = nifedipine > or = verapamil > diltiazem, which appears to parallel their antioxidant potency. In addition, (+)-nicardipine, and its pharmacologically inactive isomer, (-)-nicardipine, were similarly effective. We conclude that it was the antioxidant activity of the calcium channel blockers that preserved the cell growth capacity against free-radical damage; such protective effects may contribute to their antiatherogenic effects.
Similar articles
-
Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.Pharmacol Res. 2002 Jan;45(1):27-33. doi: 10.1006/phrs.2001.0903. Pharmacol Res. 2002. PMID: 11820858
-
Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels.Circ Res. 1992 Jun;70(6):1099-103. doi: 10.1161/01.res.70.6.1099. Circ Res. 1992. PMID: 1576732
-
Antioxidant activity of calcium channel blocking drugs.Methods Enzymol. 1994;234:620-30. doi: 10.1016/0076-6879(94)34133-8. Methods Enzymol. 1994. PMID: 7808338 No abstract available.
-
Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.Biochem Pharmacol. 1998 Jun 1;55(11):1843-52. doi: 10.1016/s0006-2952(98)00070-7. Biochem Pharmacol. 1998. PMID: 9714303
-
Protective mechanisms of Mg-gluconate against oxidative endothelial cytotoxicity.Cell Mol Biol (Noisy-le-grand). 2000 Dec;46(8):1337-44. Cell Mol Biol (Noisy-le-grand). 2000. PMID: 11156479
Cited by
-
Quantitative Estimation of the Hydrogen-Atom-Donating Ability of 4-Substituted Hantzsch Ester Radical Cations.ACS Omega. 2021 Sep 2;6(36):23621-23629. doi: 10.1021/acsomega.1c03872. eCollection 2021 Sep 14. ACS Omega. 2021. PMID: 34549160 Free PMC article.
-
Updates on Pharmacologic Management of Microvascular Angina.Cardiovasc Ther. 2022 Oct 25;2022:6080258. doi: 10.1155/2022/6080258. eCollection 2022. Cardiovasc Ther. 2022. PMID: 36382021 Free PMC article. Review.
-
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.Oxid Med Cell Longev. 2016;2016:1892412. doi: 10.1155/2016/1892412. Epub 2016 Jan 6. Oxid Med Cell Longev. 2016. PMID: 26881016 Free PMC article. Review.
-
Simvastatin combined with nifedipine enhances endothelial cell protection by inhibiting ROS generation and activating Akt phosphorylation.Acta Pharmacol Sin. 2010 Jul;31(7):813-20. doi: 10.1038/aps.2010.58. Epub 2010 Jun 21. Acta Pharmacol Sin. 2010. PMID: 20562903 Free PMC article.
-
Dihydropyridine Derivatives as Cell Growth Modulators In Vitro.Oxid Med Cell Longev. 2017;2017:4069839. doi: 10.1155/2017/4069839. Epub 2017 Apr 3. Oxid Med Cell Longev. 2017. PMID: 28473879 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical